Search icon
Learn, Analyse & Invest
only with
Orca logoArrow icon
+91
Download Orca
orca play storeorca apple store
To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

0.00

EX-DatePurpose
28 06 2021 Quarterly Results & Audited Results
12 08 2021 Audited Results
20 09 2021 Quarterly Results (Revised)
20 09 2021WANBURY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/10/2021 ,inter alia, to consider and approve This is with reference to our earlier letter dated 3rd August, 2021 and 9th August, 2021 regarding the meeting of Board of Directors of Wanbury Limited which is scheduled to be held on 20th September, 2021 inter-alia to consider and approve the Un-Audited Financial Results for the first quarter and three months ended 30th June, 2021. In this regard, we hereby inform you that the meeting is further deferred/ postponed due to the circumstances beyond our control and other administrative reasons and the Meeting of the Board of Directors is now re-scheduled to be held on Wednesday, 20th October, 2021. Further, as per SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in Securities of the Company shall now remain closed for the Companys Directors/Officers/Key Managerial Personnel/ Designated Employees of the Company w.e.f. 1st July, 2021 till the close of business hours on 22nd October, 2021 (both days inclusive).
20 10 2021 Quarterly Results
12 11 2021 Quarterly Results
25 11 2021 Quarterly Results (Revised)
08 02 2022 Quarterly Results
17 02 2022 Preferential Issue of shares Inter-alia, to consider and evaluate any and all proposals for raising of funds by way of a preferential issue/ allotment, private placement including a qualified institutions placement or foreign currency convertible bonds or tlu?ough any other permissible mode and/ or combination thereof, as may be considered appropriate, by way of issue of equity shares or warrants or other securities convertible into equity shares or bonds including foreign currency convertible bonds, convertible debentures and/or non-convertible debentures including non-convertible debentures along with warrants, which may or may not be listed. The Board, if required, would also consider conducting an extraordinary general meeting/ postal ballot process to seek approval of the shareholders in respect of the aforesaid proposal.
22 06 2022 Audited Results
10 08 2022 Quarterly Results
11 11 2022 Quarterly Results
28 11 2022 Quarterly Results (Revised)
14 02 2023 Quarterly Results
30 05 2023 Audited Results(Cancelled) (Cancelled)
30 05 2023 Audited Results
09 06 2023 Audited Results
26 06 2023 Audited Results (Revised)
11 08 2023 Quarterly Results
20 10 2023 Inter-alia, to consider and evaluate proposals for raising of funds by way of a preferential issue/allotment and private placement to promoters/promoter group of the Company, by way of issue f equity shares or warrants or other securities convertible into equity shares, which may or may not be listed.
24 01 2024 Quarterly Results
13 11 2024 Quarterly Results
12 02 2025 Quarterly Results & Inter alia, to consider and approve :- 1) the issue of senior, secured, unlisted redeemable and non- convertible debentures on private placement basis and the terms and conditions and other matters in relation to such issue.
15 05 2025 Audited Results
13 11 2025 Quarterly Results
05 02 2026 Quarterly Results

News

28-JAN-2026

Wanbury starts commercial production of high-potent anaesthetic API at Tanuku facility

The new API is expected to generate incremental revenues of around Rs 18 crore in Q4 FY 2025-26

12:50 PM
27-JUN-2025

Wanbury launches Iron supplement ‘C RED’

The product was recently launched in Northern India followed by Southern India has already garnered tremendous response from clinicians/doctors

12:39 PM
20-MAY-2025

Wanbury gets GMP certificate for Patalganga facility

On May 12, the company had received certificate from ANVISA for its Tanuku Site, Andhra Pradesh

11:43 AM
24-MAR-2025

Wanbury to launch two new products

The company is commencing supply of Ketamine during this month with export for European markets

04:48 PM
03-JAN-2025

Wanbury completes Brazilian Health Authority audit at Tanuku plant facility

This will enable the company to maintain and further solidify its position in this important market

03:59 PM
Enrich money logo